According to Yu et al., interleukin-6 (IL-6) may be a critical factor in melanocytic cytotoxicity since vitiligo patients produced significantly more IL-6 and IL-8 while releasing less TNF-α and IFN-γ (10). The gene discussed is IFNG; the disease is vitiligo.